Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | melatonin receptor 1B | Starlite/ChEMBL | References |
Homo sapiens | NAD(P)H dehydrogenase, quinone 2 | Starlite/ChEMBL | References |
Homo sapiens | melatonin receptor 1A | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | melatonin receptor 1B | 362 aa | 329 aa | 18.8 % |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | NAD(P)H dehydrogenase, quinone 2 | 231 aa | 213 aa | 26.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | ubiquitin carboxyl-terminal hydrolase domain containing protein | 0.0036 | 0.1304 | 0.5 |
Onchocerca volvulus | 0.0027 | 0 | 0.5 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Onchocerca volvulus | 0.0027 | 0 | 0.5 | |
Toxoplasma gondii | transporter, major facilitator family protein | 0.0027 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Onchocerca volvulus | Putative organic anion transporter | 0.0027 | 0 | 0.5 |
Onchocerca volvulus | 0.0027 | 0 | 0.5 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0072 | 0.6503 | 0.5979 |
Onchocerca volvulus | 0.0027 | 0 | 0.5 | |
Echinococcus multilocularis | Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 | 0.0036 | 0.1304 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Echinococcus multilocularis | ubiquitin specific protease 41 | 0.0036 | 0.1304 | 1 |
Schistosoma mansoni | ubiquitin-specific peptidase 2 (C19 family) | 0.0036 | 0.1304 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 1 | 1 |
Echinococcus multilocularis | ubiquitin carboxyl terminal hydrolase 8 | 0.0036 | 0.1304 | 1 |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.0036 | 0.1304 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0036 | 0.1304 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Echinococcus granulosus | ubiquitin specific protease 41 | 0.0036 | 0.1304 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Schistosoma mansoni | ubiquitin-specific peptidase 8 (C19 family) | 0.0036 | 0.1304 | 1 |
Onchocerca volvulus | Putative organic anion transporter | 0.0027 | 0 | 0.5 |
Trypanosoma brucei | ubiquitin carboxyl-terminal hydrolase, putative | 0.0036 | 0.1304 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Leishmania major | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative | 0.0036 | 0.1304 | 0.5 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0096 | 1 | 1 |
Onchocerca volvulus | 0.0027 | 0 | 0.5 | |
Onchocerca volvulus | Putative organic anion transporter | 0.0027 | 0 | 0.5 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0096 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Echinococcus granulosus | ubiquitin carboxyl terminal hydrolase 8 | 0.0036 | 0.1304 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1304 | 1 |
Echinococcus granulosus | Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 | 0.0036 | 0.1304 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0036 | 0.1304 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.77 nM | Inhibition of 2-[125I]-iodomelatonin binding to human Melatonin receptor type 1B expressed in HEK293 cells | ChEMBL. | 11960497 |
Ki (binding) | = 0.77 nM | Inhibition of 2-[125I]-iodomelatonin binding to human Melatonin receptor type 1B expressed in HEK293 cells | ChEMBL. | 11960497 |
Ki (binding) | = 1.1 nM | Inhibition of 2-[125I]-iodomelatonin binding to human Melatonin receptor type 1A expressed in HEK293 cells | ChEMBL. | 11960497 |
Ki (binding) | = 1.1 nM | Inhibition of 2-[125I]-iodomelatonin binding to human Melatonin receptor type 1A expressed in HEK293 cells | ChEMBL. | 11960497 |
Ki (binding) | = 6.1 nM | Inhibition of 2-[125I]-iodomelatonin binding to Melatonin receptor 3 (MT3) of Syrian hamster brain membrane | ChEMBL. | 11960497 |
Ki (binding) | = 6.1 nM | Inhibition of 2-[125I]-iodomelatonin binding to Melatonin receptor 3 (MT3) of Syrian hamster brain membrane | ChEMBL. | 11960497 |
Selectivity (binding) | = 0.12 | Selectivity ratio of binding affinity at MT2 receptor relative to MT3 receptor | ChEMBL. | 11960497 |
Selectivity (binding) | = 0.1803 | Selectivity ratio of binding affinity at MT1 receptor relative to MT3 receptor | ChEMBL. | 11960497 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.